2025 revenue consensus $5.25B.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONC:
- BeOne Medicines’ New Study on BG-75202: A Potential Game-Changer in Cancer Treatment?
- BeOne Medicines Advances in Oncology with Promising BG-T187 Study
- BeOne Medicines Advances in Multiple Myeloma Treatment with Sonrotoclax Study
- BeOne Medicines Advances CLL Treatment with Promising Phase 3 Study
- BeOne Medicines Advances CLL and SLL Treatment with Promising Phase 3 Study
